title: Genomic interaction profiles in breast cancer reveal altered chromatin architecture.
abstract: Gene transcription can be regulated by remote enhancer regions through chromosome looping either in cis or in trans. Cancer cells are characterized by wholesale changes in long-range gene interactions, but the role that these long-range interactions play in cancer progression and metastasis is not well understood. In this study, we used IGFBP3, a gene involved in breast cancer pathogenesis, as bait in a 4C-seq experiment comparing normal breast cells (HMEC) with two breast cancer cell lines (MCF7, an ER positive cell line, and MDA-MB-231, a triple negative cell line). The IGFBP3 long-range interaction profile was substantially altered in breast cancer. Many interactions seen in normal breast cells are lost and novel interactions appear in cancer lines. We found that in HMEC, the breast carcinoma amplified sequence gene family (BCAS) 1-4 were among the top 10 most significantly enriched regions of interaction with IGFBP3. 3D-FISH analysis indicated that the translocation-prone BCAS genes, which are located on chromosomes 1, 17, and 20, are in close physical proximity with IGFBP3 and each other in normal breast cells. We also found that epidermal growth factor receptor (EGFR), a gene implicated in tumorigenesis, interacts significantly with IGFBP3 and that this interaction may play a role in their regulation. Breakpoint analysis suggests that when an IGFBP3 interacting region undergoes a translocation an additional interaction detectable by 4C is gained. Overall, our data from multiple lines of evidence suggest an important role for long-range chromosomal interactions in the pathogenesis of cancer.
authors.affiliation: Department of Medicine, Veterans Affairs Palo Alto Health Care System, Stanford University Medical School, Palo Alto, California, United States of America.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Zeitz
authors.forename: Ferhat
authors.initials: F
authors.lastname: Ay
authors.forename: Julia D
authors.initials: JD
authors.lastname: Heidmann
authors.forename: Paula L
authors.initials: PL
authors.lastname: Lerner
authors.forename: William S
authors.initials: WS
authors.lastname: Noble
authors.forename: Brandon N
authors.initials: BN
authors.lastname: Steelman
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Hoffman
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D045744:Cell Line, Tumor; D002843:Chromatin / Q000235:genetics*; D002869:Chromosome Aberrations; D019175:DNA Methylation; D015536:Down-Regulation; D005260:Female; D015894:Genome, Human; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000235:genetics; D009363:Neoplasm Proteins / Q000235:genetics; D011401:Promoter Regions, Genetic; D014158:Transcription, Genetic; D015854:Up-Regulation
chemical_list: C113699:BCAS1 protein, human; D002843:Chromatin; C515497:IGFBP3 protein, human; D018972:Insulin-Like Growth Factor Binding Protein 3; D009363:Neoplasm Proteins
references.citation: Clin Cancer Res. 1995 Dec;1(12):1455-61
references.pmid: 9815944
references.citation: Science. 2009 Nov 27;326(5957):1230
references.pmid: 19933109
references.citation: Curr Opin Genet Dev. 2007 Oct;17(5):435-42
references.pmid: 17905579
references.citation: Cancer Res. 2004 Nov 1;64(21):7711-23
references.pmid: 15520175
references.citation: J Biol Chem. 1997 May 2;272(18):12181-8
references.pmid: 9115291
references.citation: EMBO J. 1993 Mar;12(3):1059-65
references.pmid: 8458323
references.citation: Genome Biol. 2010;11(3):204
references.pmid: 20353545
references.citation: Cell. 2009 Dec 11;139(6):1069-83
references.pmid: 19962179
references.citation: Mol Cell. 2012 Sep 28;47(6):873-85
references.pmid: 22864115
references.citation: J Comput Biol. 2005 Oct;12(8):1047-64
references.pmid: 16241897
references.citation: Int J Cancer. 2004 Aug 20;111(2):293-7
references.pmid: 15197785
references.citation: Nat Genet. 2010 Jan;42(1):53-61
references.pmid: 20010836
references.citation: Science. 2009 Oct 9;326(5950):289-93
references.pmid: 19815776
references.citation: Nature. 2009 Dec 24;462(7276):1005-10
references.pmid: 20033038
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19199-204
references.pmid: 19052240
references.citation: Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
references.pmid: 12184808
references.citation: Oncogene. 2013 May 9;32(19):2412-20
references.pmid: 22751133
references.citation: Cancer Res. 2009 Dec 1;69(23):8877-85
references.pmid: 19903847
references.citation: Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2156-60
references.pmid: 8134364
references.citation: J Cell Biol. 2008 Jan 14;180(1):39-50
references.pmid: 18195100
references.citation: Genome Res. 2009 Feb;19(2):167-77
references.pmid: 19056696
references.citation: Science. 2006 Apr 14;312(5771):269-72
references.pmid: 16614224
references.citation: Biochem Biophys Res Commun. 2005 Mar 11;328(2):393-8
references.pmid: 15694360
references.citation: Methods. 2012 Nov;58(3):221-30
references.pmid: 22609568
references.citation: Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9083-8
references.pmid: 22615383
references.citation: Genes Chromosomes Cancer. 2002 Dec;35(4):311-7
references.pmid: 12378525
references.citation: Nat Cell Biol. 2006 Mar;8(3):293-9
references.pmid: 16434960
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):763-8
references.pmid: 17416768
references.citation: J Biol Chem. 1993 Dec 15;268(35):26045-8
references.pmid: 7504671
references.citation: Hum Mol Genet. 2010 Mar 1;19(5):901-19
references.pmid: 20015958
references.citation: Nature. 2008 Mar 13;452(7184):187-93
references.pmid: 18337816
references.citation: Int J Cancer. 1998 Dec 18;79(6):624-8
references.pmid: 9842972
references.citation: Nature. 2012 Oct 4;490(7418):61-70
references.pmid: 23000897
references.citation: Cancer Res. 2008 Oct 15;68(20):8322-32
references.pmid: 18922904
references.citation: Nature. 2010 May 20;465(7296):363-7
references.pmid: 20436457
references.citation: Blood. 1999 Feb 15;93(4):1197-207
references.pmid: 9949162
references.citation: Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4364-9
references.pmid: 21368160
references.citation: Cell. 2012 Mar 2;148(5):908-21
references.pmid: 22341456
references.citation: Science. 2011 Oct 14;334(6053):222-5
references.pmid: 21998387
references.citation: Endocr Rev. 2002 Dec;23(6):824-54
references.pmid: 12466191
references.citation: Nature. 2005 Jun 2;435(7042):637-45
references.pmid: 15880101
references.citation: Methods Mol Biol. 2012;786:211-25
references.pmid: 21938629
references.citation: Genome Res. 2010 Jun;20(6):761-70
references.pmid: 20430782
references.citation: Crit Rev Oncol Hematol. 1995 Jul;19(3):183-232
references.pmid: 7612182
references.citation: Science. 2006 Feb 24;311(5764):1149-52
references.pmid: 16424298
references.citation: Nat Biotechnol. 2011 Dec 25;30(1):90-8
references.pmid: 22198700
references.citation: Genome Res. 2007 Jun;17(6):828-38
references.pmid: 17568001
references.citation: Endocr Relat Cancer. 2006 Jun;13(2):593-605
references.pmid: 16728585
references.citation: J Clin Endocrinol Metab. 2004 Apr;89(4):1950-6
references.pmid: 15070968
references.citation: Nucleic Acids Res. 2001 May 1;29(9):e45
references.pmid: 11328886
references.citation: J Cell Biol. 2009 Dec 14;187(6):801-12
references.pmid: 19995938
references.citation: Cell. 2012 Jan 20;148(1-2):84-98
references.pmid: 22265404
references.citation: Cell Cycle. 2006 Jul;5(13):1407-10
references.pmid: 16855396
references.citation: Nature. 2009 Nov 5;462(7269):58-64
references.pmid: 19890323
references.citation: Lancet Oncol. 2010 Jun;11(6):530-42
references.pmid: 20472501
references.citation: Nature. 2011 May 5;473(7345):43-9
references.pmid: 21441907
references.citation: J Endocrinol. 2002 Oct;175(1):19-31
references.pmid: 12379487
references.citation: Nat Cell Biol. 2001 Sep;3(9):802-8
references.pmid: 11533659
references.citation: Clin Cancer Res. 1997 Jan;3(1):103-9
references.pmid: 9815544
references.citation: Nature. 2012 Apr 04;486(7403):395-9
references.pmid: 22495314
references.citation: Genome Res. 2007 Jun;17(6):877-85
references.pmid: 17179217
references.citation: Nat Genet. 2003 Jul;34(3):287-91
references.pmid: 12808455
references.citation: Nat Rev Genet. 2007 Apr;8(4):286-98
references.pmid: 17339880
references.citation: Int J Cancer. 2007 Feb 1;120(3):566-73
references.pmid: 17096329
references.citation: Cancer Res. 2011 Aug 1;71(15):5154-63
references.pmid: 21697285
references.citation: Cell. 2007 Feb 23;128(4):787-800
references.pmid: 17320514